BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 37238943)

  • 1. Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain.
    Shahbazi A; Sepehrinezhad A; Vahdani E; Jamali R; Ghasempour M; Massoudian S; Sahab Negah S; Larsen FS
    Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Link between Gut Microbiota and Hepatic Encephalopathy.
    Won SM; Oh KK; Gupta H; Ganesan R; Sharma SP; Jeong JJ; Yoon SJ; Jeong MK; Min BH; Hyun JY; Park HJ; Eom JA; Lee SB; Cha MG; Kwon GH; Choi MR; Kim DJ; Suk KT
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy
    Luo M; Xin RJ; Hu FR; Yao L; Hu SJ; Bai FH
    World J Gastroenterol; 2023 Jan; 29(1):144-156. PubMed ID: 36683714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective.
    Samanta A; Sen Sarma M
    World J Hepatol; 2024 May; 16(5):678-683. PubMed ID: 38818298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis.
    Zhu R; Liu L; Zhang G; Dong J; Ren Z; Li Z
    Biosci Rep; 2023 Jun; 43(6):. PubMed ID: 37279097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective.
    Liu J; Xu Y; Jiang B
    Front Cell Infect Microbiol; 2021; 11():586427. PubMed ID: 33692964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Gut Dysbiosis in the Pathophysiology of Neuropsychiatric Disorders.
    Anand N; Gorantla VR; Chidambaram SB
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Barrier and Microbiota in Cirrhosis.
    Philips CA; Augustine P
    J Clin Exp Hepatol; 2022; 12(2):625-638. PubMed ID: 35535069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis.
    Campion D; Giovo I; Ponzo P; Saracco GM; Balzola F; Alessandria C
    World J Hepatol; 2019 Jun; 11(6):489-512. PubMed ID: 31293718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota-Gut-Brain Axis: Pathophysiological Mechanism in Neuropsychiatric Disorders.
    Shin C; Kim YK
    Adv Exp Med Biol; 2023; 1411():17-37. PubMed ID: 36949304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota.
    Salminen A
    J Mol Med (Berl); 2023 Mar; 101(3):201-222. PubMed ID: 36757399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpharmacologic Management of Hepatic Encephalopathy: An Update.
    Weir V; Reddy KR
    Clin Liver Dis; 2020 May; 24(2):243-261. PubMed ID: 32245531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment.
    Varesi A; Pierella E; Romeo M; Piccini GB; Alfano C; Bjørklund G; Oppong A; Ricevuti G; Esposito C; Chirumbolo S; Pascale A
    Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration.
    Solanki R; Karande A; Ranganathan P
    Front Neurol; 2023; 14():1149618. PubMed ID: 37255721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the blood-brain barrier to delay aging-accompanied neurological diseases by modulating gut microbiota, circadian rhythms, and their interplays.
    Wang Y; Du W; Hu X; Yu X; Guo C; Jin X; Wang W
    Acta Pharm Sin B; 2023 Dec; 13(12):4667-4687. PubMed ID: 38045038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Pesticide Residues on the Gut-Microbiota-Blood-Brain Barrier Axis: A Narrative Review.
    Abou Diwan M; Lahimer M; Bach V; Gosselet F; Khorsi-Cauet H; Candela P
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy.
    Li Z; Zhang F; Sun M; Liu J; Zhao L; Liu S; Li S; Wang B
    PeerJ; 2023; 11():e15122. PubMed ID: 37009158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
    Sajdel-Sulkowska EM
    Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives.
    Rocco A; Sgamato C; Compare D; Coccoli P; Nardone OM; Nardone G
    Front Cell Dev Biol; 2021; 9():748253. PubMed ID: 34900994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder.
    Srikantha P; Mohajeri MH
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.